bisacurone: an NSAID isolated from Curcuma longa; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 14287397 |
| MeSH ID | M0525495 |
| Synonym |
|---|
| bisacurone |
| 120681-81-4 |
| FS-8794 |
| sa836ufa35 , |
| unii-sa836ufa35 |
| (6s)-6-[(1r,4s,5s)-4,5-dihydroxy-4-methylcyclohex-2-en-1-yl]-2-methylhept-2-en-4-one |
| DTXSID501336136 |
| 2-hepten-4-one, 6-[(1r,4s,5s)-4,5-dihydroxy-4-methyl-2-cyclohexen-1-yl]-2-methyl-, (6s)- |
| (6s)-6-[(1r,4s,5s)-4,5-dihydroxy-4-methyl-2-cyclohexen-1-yl]-2-methyl-2-hepten-4-one |
| AKOS040761417 |
| Excerpt | Reference | Relevance |
|---|---|---|
| " However, studies have indicated that turmeric oil, present in turmeric, can enhance the bioavailability of curcumin." | ( Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: Identification of novel components of turmeric. Aggarwal, BB; Gupta, SC; Li, S; Yuan, W, 2013) | 0.39 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 5 (50.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (28.27) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (10.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (90.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||